Clinical Trial Update: Tranexamic Acid to Reduce Blood Loss in Spine Surgery [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial is evaluating tranexamic acid to reduce blood loss during spine surgery, with recruitment ongoing for conditions involving spinal inj…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Deformity
• Spinal Injury

Drugs mentioned

• TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Columbia University | Conditions: Spinal Injuries, Spinal Deformity | Phase 2, Phase 3 | Status: RECRUITING